Goldman Sachs’s Surrozen SRZN Stock Holding History

Goldman Sachs’s Portfolio SRZN Stock Details SRZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.95M	Buy	113,531 +87,680	+339%	+$2.41M	﹤0.01%	4357
2026 Q1	$753K	Buy	25,851 +28	+0.1%	+$671	﹤0.01%	5300
2025 Q4	$584K	Buy	+25,823	New	+$418K	﹤0.01%	5498

Other funds holding SRZN

Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs's SRZN Position: Q2 2026 in Review

Goldman Sachs increased its Surrozen (SRZN) stake by 339% in Q2 2026, buying an estimated $2.41M and bringing the position to 113,531 shares worth $2.95M. The position accounts for ﹤0.01% of the portfolio, ranked #4357.

Goldman Sachs first reported a position in SRZN in Q4 2025 and has held it in 3 quarters since. 70 funds tracked by Wall St. Rank hold SRZN as of Q2 2026.

Goldman Sachs held 113,531 shares of Surrozen worth $2.95M as of Q2 2026.
Goldman Sachs bought 87,680 Surrozen shares in Q2 2026, an estimated $2.41M.
Surrozen made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4357 holding.
Goldman Sachs first reported a position in Surrozen in Q4 2025 and has held it in 3 quarters since.
70 funds tracked by Wall St. Rank held Surrozen as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.